Name | N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide |
---|---|
Synonyms |
Cyclopropanecarboxylic acid-(3-(4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino)-phenyl)-amide
Anilinopyrimidine1 2np8 Aurora Kinase Inhibitor III N-{3-[(4-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-2-yl)amino]phenyl}cyclopropanecarboxamide |
Description | Aurora Kinase Inhibitor 3 is a strong and selective Aurora A kinase inhibitor with an IC50 of 42 nM, and weakly inhibits EGFR with an IC50>10 μM. Aurora Kinase Inhibitor 3 has a binding mode with the cyclopropanecarboxylic acid moiety directed towards the solvent exposed region of the ATP-binding pocket, and several induced structural changes in the active-site compared with other published AIK structures[1]. |
---|---|
Related Catalog | |
Target |
Aurora A:42 nM (IC50) |
References |
Molecular Formula | C21H18F3N5O |
---|---|
Molecular Weight | 413.39600 |
Exact Mass | 413.14600 |
PSA | 85.66000 |
LogP | 5.47550 |
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 2933599090 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |